IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness

Journal for ImmunoTherapy of Cancer - Tập 1 - Trang 1-1 - 2013
C Bryce Johnson1, Bennett R May1, Colleen A Cloud1, Mark P Rubinstein1, David J Cole
1Medical University of South Carolina, Charleston, USA